Finwise Bancorp Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Finwise Bancorp (FINW) on October 6, 2022. The filing addresses significant changes to the Company's Board of Directors and executive leadership, as well as a resulting compliance issue with Nasdaq listing requirements.
Key Financial Metrics
The filing text does not provide comprehensive financial metrics such as revenue, profit, cash flow, margins, or total debt. The only specific financial figures disclosed relate to a secured promissory note involving a director:
- Director Loan: A secured promissory note (2022 Note) with a principal amount of $143,410 owed by Mr. Alan Weichselbaum to the Company.
- Loan Terms: 4% annual interest rate, maturing December 31, 2022, secured by 30,000 shares of common stock.
- Recent Payments: On June 1, 2022, the Company received $3,524 in interest and a $2,868 renewal fee from Mr. Weichselbaum.
Material Changes
The following material changes occurred on October 6, 2022:
- Resignation of Chairman: Mr. Russell F. Healey, Jr. resigned from the Board of Directors and all committees (Audit, Compensation, Nominating & Corporate Governance) for health reasons.
- Nasdaq Compliance Issue: The resignation caused the Company to fail Nasdaq Listing Rule 5605 regarding audit committee composition. The Company has been granted a cure period until the earlier of its next annual shareholders meeting or October 6, 2023.
- Board Appointments:
- Mr. Alan Weichselbaum was elected as a Class I director.
- Mr. Kent Landvatter (CEO) was appointed Chairman of the Board.
- Mr. Howard I. Reynolds was appointed Lead Independent Director.
- Executive Appointment: James Noone was appointed Chief Strategy Officer & Chief Credit Officer and Executive Vice President of FinWise Bank.
Outlook, Risks, and Contingencies
The Company intends to regain compliance with Nasdaq audit committee requirements within the provided cure period. The filing includes a "Safe Harbor" statement noting that forward-looking statements are subject to risks, specifically the ability to identify, attract, and retain suitable prospective directors. The Company cautions that actual results may differ materially from expectations due to these uncertainties.
Investor Verification Checklist
- Verify the timeline for appointing a new qualified audit committee member to satisfy Nasdaq Rule 5605.
- Confirm the status of the $143,410 promissory note owed by the newly elected director, Mr. Weichselbaum, and its impact on related party transactions.
- Review the Company's subsequent filings for updates on the resignation of Mr. Healey and the stability of the new board leadership.
- Check for any additional disclosures regarding the health reasons for Mr. Healey's resignation if further details are provided in future reports.